Podcasts about Johns Hopkins

Dr. Sam Zand is a holistic psychiatrist, educator, and entrepreneur dedicated to merging traditional psychiatry with innovative neuroplastic therapies.A Johns Hopkins graduate and Professor of Psychedelic Medicine at UNLV, he founded Anywhere Clinic and Calm Clinic to expand global access to telepsychiatry and integrative care. From utilizing TMS and Ketamine-Assisted Therapy to leading philanthropic efforts through the Better Universe Foundation, Dr. Zand is a leading voice in the "mental health revolution," focused on systemic reform and aligning personal mission with daily well-being.Dr. Sam Zand's website: https://www.drsamzand.com/Anywhere Clinic: https://www.anywhereclinic.com/Better U (ketamine therapy platform): https://www.betterucare.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.---Thank you for listening!If you want to support the show, I've got three options and every bit helps.$5.00 PayPalhttps://www.paypal.com/ncp/payment/NPKS32G8KVSN2$10.00 PayPalhttps://www.paypal.com/ncp/payment/495AMDFXQFC3L$15.00 PayPalhttps://www.paypal.com/ncp/payment/M7V5RREUKVD8JThank you to our Sponsors: Jane App - use code GUY1MO at https://janesoftware.partnerlinks.io/ngvcwcxqt2jx-4afv8i (https://jane.app/book_a_demo)Novo Psych - novopsych.com/traumapodcastRebound - https://hellorebound.com/tt

In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern  about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dementia, new screwworm cases, the Ebola outbreak in the Congo and Uganda and where the hantavirus outbreak began, before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, Virgina outbreak of measles, how to access and pay for Paxlovid, how more people were negatively impacted by influenza than COVID, discontinuing contact precautions for COVID, where to go for answers about long COVID-19, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Today we filed a motion asking the First Circuit to expedite our appeal of the district court's order in the AAP lawsuit that left ACIP—the nation's vaccine advisory committee—without a quorum (X) CDC advisers drop decades-old universal hepatitis B birth dose recommendation, suggest blood testing after 1 dose (CIDRAP) HHS asks for expedited appeal of court ruling on US vaccine policy (CIDRAP) New Plan Scales Back C.D.C.'s Work on Diseases Abroad (NY Times) Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms (CID) Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years (OFID) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Head-to-head comparison suggests flu was much more likely to lead to hospitalization than COVID last winter (CIDRAP) FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats (FDA) Fact Sheet: Emergency Use Authorization of Nitenpyram Tablets (nitenpyram) for New World Screwworm (NWS) (FDA) Ebola dashboard (ebola.fyi)  EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Big Ebola outbreak puts spotlight on little known virus (Science) Ebola outbreak spreads to crowded displacement camp in Congo (Reuters) Ebola outbreak in DR Congo expands into large displacement camp (CIDRAP) Congo Ebola outbreak may be worst ever, Africa CDC says (Reuters) Advocacy groups are urging the release of the monoclonal antibody MBP134 and any other requested investigational therapeutics (Citizen.org) Hantavirus dashboard (Hantavirus.up Hantavirus on board with Prof. Vincent Racaniello (microbeTV) How did the cruise ship hantavirus outbreak start? (Science) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard( South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) US measles cases continue to climb, especially in Virginia(CIDRAP) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Anguished Parents, Crying Doctors: Life Amid Utah's Measles Outbreak (Wired) Characteristics of Patients Hospitalized with Measles During an Outbreak — West Texas, January–March 2025 (CDC:MMWR) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025 (JAMA Network OPEN) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Seasonal influenza versus COVID-19 hospitalisation risk during the 2025–26 influenza season (LANCET: Infectious Diseases) Discontinuingcontact precautions for COVID-19: the science says its time (Infection Control and Hospital Epidemiology) 2024-2025 COVID-19 Vaccine and Major Adverse Cardiovascular Events Among US Veterans (JAMA Internal Medicine) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1332 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Making CAR-T cells from donor bone marrow already used to treat someone's cancer helped rein in cancer recurrence, a new study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins says this is one more place where an expansion … Can a new method for developing CAR-T cells to treat cancer be expanded? Elizabeth Tracey reports Read More »

Along with longer days and warmer temperatures, summer heralds much more robust mosquito populations in the northern hemisphere. Johns Hopkins mosquito expert Christopher Potter describes the three species of mosquitoes found worldwide and the illnesses they're associated with. Potter: There … Now that summer is here mosquitoes are all around us, Elizabeth Tracey reports Read More »

Dr. Jennifer Miles-Thomas is Vice Chair of Integration and Innovation at Northwestern Medicine, Executive Treasurer of the American Urological Association, and a former CEO of one of the largest private urology groups in the country. She earned her MD at Northwestern, completed her residency and fellowship at Johns Hopkins, and her MBA at MIT Sloan. In this episode of DGTL Voices, Jennifer talks with Ed about the spinal meningitis diagnosis at age three that pointed her toward medicine, what changed when she got to MIT and started thinking alongside multinational CFOs and SpaceX engineers, and why she left a CEO seat for protected innovation time at a health system. She shares her perspective as a Black female urologist on what it took to navigate her training, how she leads through really listening, and why she believes failure is part of the path to anything worth building. https://marxadvisory.com

Saturn's moon Titan is one of the most Earth-like worlds in our Solar System, with a dense nitrogen atmosphere, weather cycles, methane rivers, and vast organic dune fields. It also happens to be the perfect place to fly a drone. NASA's Dragonfly mission is doing exactly that, sending a car-sized, nuclear-powered rotorcraft to explore Titan's surface starting in 2034. With just two years until launch, the team is deep in the work of making it happen. This week, we're joined by two members of the Dragonfly team from the Johns Hopkins Applied Physics Laboratory. Felipe Ruiz is the mission's lead rotor engineer and mechanical implementation lead, responsible for designing the eight-rotor system that will carry Dragonfly across Titan's skies. Zibi Turtle is the mission's principal investigator, a planetary scientist whose career has spanned missions from Galileo to Cassini to Europa Clipper. Together, they walk us through the engineering challenges of flying a thousand-kilogram rotorcraft in an alien atmosphere, how the team is testing and validating the design here on Earth, and what the spacecraft's instruments will look for on Titan's surface. Then Bruce Betts, our chief scientist, joins us for What's Up, where we pay tribute to the Ingenuity Mars helicopter and the legacy of the first powered, controlled flight on another world. Discover more at: https://www.planetary.org/planetary-radio/2026-engineering-of-dragonflySee omnystudio.com/listener for privacy information.

Jessica and Dave sit down with Noel and Richard Paschke—known throughout dentistry as Mr. and Mrs. Ultrasonics.   Noel, a pioneering dental hygienist, educator, inventor, and industry leader, joins her husband Rich, an ultrasonic engineer and innovator, to share the story behind their partnership and the impact they've had on ultrasonic scaling technology.   Together, they discuss how clinical experience and engineering expertise came together to drive product innovation, improve ergonomics, and shape many of the ultrasonic technologies clinicians use today. They also share insights into the invention process, life after retirement, and exciting new technologies currently in development.   In this episode, you'll learn:   How Rich transitioned from military engineering to dentistry   Noel's journey from Johns Hopkins to industry leadership   The clinician-first approach that changed ultrasonic product design   Products and patents that have influenced modern scaling   What's next for the future of ultrasonics   Connect with Noel: noel.ultrasonicsplus@gmail.com LinkedIn: https://www.linkedin.com/in/noelpaschke/   Contact the Hosts: Jessica Atkinson: jatkinson@endeavorb2b.com Dave Torres: dtorres@endeavorb2b.com

Jessica and Dave sit down with Noel and Richard Paschke—known throughout dentistry as Mr. and Mrs. Ultrasonics.   Noel, a pioneering dental hygienist, educator, inventor, and industry leader, joins her husband Rich, an ultrasonic engineer and innovator, to share the story behind their partnership and the impact they've had on ultrasonic scaling technology.   Together, they discuss how clinical experience and engineering expertise came together to drive product innovation, improve ergonomics, and shape many of the ultrasonic technologies clinicians use today. They also share insights into the invention process, life after retirement, and exciting new technologies currently in development.   In this episode, you'll learn:   How Rich transitioned from military engineering to dentistry   Noel's journey from Johns Hopkins to industry leadership   The clinician-first approach that changed ultrasonic product design   Products and patents that have influenced modern scaling   What's next for the future of ultrasonics   Connect with Noel: noel.ultrasonicsplus@gmail.com LinkedIn: https://www.linkedin.com/in/noelpaschke/   Contact the Hosts: Jessica Atkinson: jatkinson@endeavorb2b.com Dave Torres: dtorres@endeavorb2b.com

Messenger RNA (mRNA) plays a literally central role in the functioning of life as we know it, shuttling information back and forth between the DNA where it is stored to the ribosome where it is used to produce proteins. RNA may even have been the first molecule to kick-start the origin of life. Today, scientists are learning how to manipulate mRNA to cure and prevent diseases, whether through vaccination or literally editing one's DNA. Jeff Coller explains how it all works and how mRNA is revolutionizing medicine as we know it. Blog post with transcript: https://www.preposterousuniverse.com/podcast/2026/06/15/357-jeff-coller-on-mrna-vaccines-and-bespoke-therapeutics/ Support Mindscape on Patreon. Jeff Coller received his Ph.D. in cell and molecular biology from the University of Wisconsin-Madison. He is currently Bloomberg Distinguished Professor of Biomedical Engineering and Director of the RNA Innovation Center at Johns Hopkins University. He is co-founder of Tevard Biosciences and the Alliance for mRNA Medicines, and leads the REPAIRx consortium. He is a fellow of the American Association for the Advancement of Science. Web site Johns Hopkins web page Google Scholar publications "This May Be the Most Important Medical Story of the Decade," New York Times, April 9, 2026

Brian Platzer is the critically acclaimed author of the novels The Optimists (Little, Brown), Bed-Stuy Is Burning and The Body Politic (both Atria/Simon & Schuster), as well as the parenting book Taking the Stress Out of Homework (Avery/Penguin Random House).  He has written frequently for The New York Times, NewYorker.com, New York Magazine, The New Republic, and many other publications. As a novelist, Brian has toured the country discussing the craft of writing as well as the issues at the heart of his work, such as education, gentrification, chronic illness, relationships, and American politics. As a humor writer, Brian has frequently written for The New Yorker's Shouts and Murmurs and McSweeney's Internet Tendency.  He recently wrote the viral article “Paw Patrol Is Contemptable Trash”; in New York Magazine, and he has performed comic essays on NPR as a featured guest on Live From Here. As an educator, Brian currently teaches 8th and 12th grade English at Grace Church School in Manhattan, having previously taught literature and writing at Johns Hopkins. Brian is a CNN contributor on education, and wrote, with Abby Freireich, the weekly “Homeroom”; column in The Atlantic as well as various articles on study skills for the New York Times. Brian is also the co-founder with Abby of Teachers Who Tutor|NYC, New York City's only tutoring company where all the tutors are classroom teachers with master's degrees. Together, Brian and Abby are among the city's leaders in education-consulting, tutoring, and executive function coaching. Brian suffers from chronic dizziness and has written a series of essays for the New York Times chronicling his experiences and those of fellow sufferers. Brian is a graduate of Grace Church School, Dalton, Columbia, and Johns Hopkins University. He currently lives in Bed-Stuy, Brooklyn with his sons and his brilliant wife, Alex Hardiman. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In his weekly clinical update, Daniel Griffin and Vincent Racaniello opine on the recent executive order on the routine childhood vaccination schedule, the Ebola outbreak in the Congo and Uganda including the fast track trials for 2 vaccine candidates and antivirals, recent Hantavirus infections, use of quarantined "Hantavirus" patients for the governmental propaganda machine, use of ribavirin and other antivirals for Hantavirus associated cardiopulmonary disease, before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the measles outbreak in Bangladesh, as well as in a daycare center in Texas in 2025, how to access and pay for Paxlovid, FDA approval of a second COVID-19 antiviral drug, where to go for answers about long COVID-19, use of convalescent sera for COVID-19 treatment and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Childhood Vaccine Hesitancy (NEJM) One Year In: Public Views of a Changing Public Health Landscape (Harvard School of Public Health) Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024 (Pediatrics) Texas reports New World screwworm in 3-week-old calf (CIDRAP) USDA Confirms First Case of New World Screwworm in a Dog in Lea County, New Mexico, Fourth Case in Texas (USDA: Animal and Plant Health Inspection Service) Confirmed Detections of New World Screwworm (USDA: Animal and Plant Health Inspection Service) Mexico reports more human New World screwworm infections (CIDRAP) Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study (Journal of Travel Medicine) Ebola dashboard (ebola.fyi)  EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Modeled Scenario Projections for the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026 (CDC: MMWR) Assessment of Riskto the U.S. Population from the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026 (CDC: MMWR) How Ebola Disease Spreads (CDC: Ebola) Signs and Symptoms of Ebola Disease (CDC: Ebola) Hantavirusdashboard (Hantavirus.up) Hantavirus on board with Prof. VincentRacaniello (MicrobeTV) Some hantavirus-exposed cruise ship passengers return home to finish quarantine (CNN) Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons (LANCET: Infectious Diseases) First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib (Clinical Microbiology and Infection) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Anguished Parents, Crying Doctors: Life Amid Utah's Measles Outbreak (Wired) Characteristics of Patients Hospitalized with Measles During an Outbreak — West Texas, January–March 2025 (CDC:MMWR) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France (LANCET: Microbe) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national andregional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure (Businesswire) SARS-CoV-2 viral shedding and vaccination‑modified effects of oral antivirals in older COVID-19 patients: a retrospective cohort study in Hong Kong (International Journal of Infectious Diseases) SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial (CID) Reaching out to US house representative Letters read on TWiV 1330 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

How to Reverse Cognitive Decline, Grow Your Hippocampus, and Protect Your Brain from Alzheimer's Disease with Nutrition, Exercise, Sleep, and Stress Reduction Your brain is physically shrinking right now, and most people have no idea it's happening. In this episode, you will discover the exact mechanisms behind cognitive decline, why brain fog is always treatable, and the proven strategies to grow your brain back, protect your memory, and slash your Alzheimer's risk regardless of your genetics. -Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Dr. Majid Fotuhi, a neuroscientist and neurologist who earned his PhD from Johns Hopkins University and his medical degree from Harvard Medical School. He currently serves as an adjunct professor at the Mind/Brain Institute at Johns Hopkins while also teaching at George Washington University and Harvard Medical School. With 37 years of experience in clinical practice, teaching, and neuroscience research, Dr. Fotuhi pioneered the Brain Fitness Program, a multidisciplinary approach to cognitive performance and brain vitality at any age that has produced measurable results documented in peer-reviewed journals. He is the author of three books including the bestselling The Invincible Brain and one of the world's leading experts on neuroplasticity, hippocampus growth, and successful aging. If anyone has earned the right to tell you your brain can get better, it is him. Dr. Fotuhi and Dave break down why Alzheimer's is not a single disease but a soup of modifiable problems, why your lab results can show "normal" while your brain is starving, and how the five pillars of brain health connect directly to longevity, mitochondria function, and human performance. They also get into the brain effects of GLP-1s, the therapeutic promise of psychedelics like psilocybin and ketamine, the role of nootropics and supplements like B12, lithium orotate, and CoQ10, and why your VO2 max may be the single most important number for brain aging. . You'll Learn: Why 97% of Alzheimer's cases involve multiple modifiable causes and what to do about each one How to physically grow your hippocampus through exercise, meditation, and nutrition Why "normal" lab ranges are actively harming millions of people and what optimal actually looks like The 7 everyday things that are shrinking your brain right now How stress, loneliness, and isolation cause measurable brain atrophy Which supplements including B12, lithium orotate, CoQ10, and nootropics support long-term brain health Why VO2 max predicts brain aging better than almost any other marker What psychedelics like psilocybin and ketamine actually do to your brain according to a Johns Hopkins neurologist How the APOE4 gene affects Alzheimer's risk and why exercise can erase that risk entirely Why mitochondria health is the foundation of both brain function and longevity Thank you to our sponsors! - Viome | Check it out at viome.com and use code 10DAVE for 10% off. It's time to stop guessing and start knowing your body. - BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. - Pique | Go to Piquelife.com/dave for 20% off. - BodyHealth | Visit BodyHeath.com and use code DAVE20 for 20% off your first purchase Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights inhealth, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: Majid Fotuhi, Dr. Majid Fotuhi, The Invincible Brain, brain health, cognitive decline, Alzheimer's prevention, hippocampus, neuroplasticity, brain fog, memory loss, APOE4, brain shrinkage, B12 deficiency, lithium orotate, CoQ10, nootropics, VO2 max, mitochondria, longevity, anti-aging, biohacking, brain optimization, sleep optimization, stress reduction, functional medicine, human performance, psilocybin, ketamine, GLP-1, semaglutide, telomeres, BDNF, brain training, cognitive performance Resources: • Learn More About Dr. Fotuhi's Work At: https://drfotuhi.com/ • Purchase Dr. Fotuhi's New Book The Invincible Brain: https://a.co/d/0iHCgPpL • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Trailer 00:59 – Intro 03:00 – Cannabis & Nicotine 04:15 – Understanding Alzheimer's 05:38 – Five Pillars Explained 07:55 – Best Cognitive Training 09:08 – Brain Size & Growth 12:36 – B12 & Lab Ranges 17:48 – Head-to-Toe Evaluation 24:17 – Sex & Brain Health 25:43 – Loneliness & Isolation 33:59 – ApoE4 Genetics 35:28 – Alzheimer's Declining 48:44 – Lithium & Brain 59:38 – VO2 Max & Fitness 1:06:42 – Psychedelics 1:09:38 – GLP-1s & Brain 1:12:38 – Closing & Action Steps See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

You don't need Johns Hopkins to become a nurse. You don't even need four years. On this Laurel Ridge Community College edition of The Valley Today, host Janet Michael is back on the Zooms with Director of Marketing Guy Curtis, joined by Dr. Scott Vanderkooi, Dean of Health Professions, and Dr. Amanda Hodges, Interim Director of Nursing — to talk about how someone in this region can become a working RN in two years, often for far less money than they assume, and with a 100% job placement rate to show for it. The bigger news in this conversation is the launch of a brand-new weekend-and-online cohort starting in spring 2027, designed specifically for people who can't quit their jobs to go back to school. Online lectures, weekend labs, weekend clinicals — built around the reality that most adult learners are already working. Amanda walks through what the program looks like, who it's right for, and how CNAs, LPNs, EMTs, paramedics, and even total beginners can step in. Plus: how G3 state funding can cover the last dollar of tuition for eligible Virginia residents, and the upcoming online information sessions where you can learn more. ABOUT THE NEW WEEKEND RN COHORT Launching spring 2027, Laurel Ridge's new RN nursing cohort is built for adult learners who can't step away from full-time work. Lectures and coursework are delivered online. Labs, simulations, and clinical hours run on weekends. The program leads to an RN license — the same credential as the traditional weekday program — and qualifies for G3 last-dollar tuition funding for eligible Virginia residents. WHO IT'S FOR • Adults currently working who want to change careers • CNAs, LPNs, EMTs, paramedics, and surgical techs looking to advance to RN • People with no prior healthcare experience who want to enter the field • Anyone who needs to keep their current job while going to nursing school INFORMATION SESSIONS • First session: Monday, June 23, 2026 — online • Additional sessions throughout July (dates listed at laurelridge.edu/nursing) • Sessions cover the new weekend cohort, the traditional RN program, the CNA program, and the Practical Nursing program — plus admission requirements, the entrance exam, and how to prepare. Parents of high school students considering nursing careers are welcome to attend. ABOUT G3 FUNDING G3 (Get Skilled, Get a Job, Give Back) is a Virginia state program that covers the "last dollar" of tuition costs for high-demand career programs at Virginia community colleges. Eligibility is based on household income — roughly $100,000 to $128,000 depending on household size — and Virginia residency. G3 stacks on top of any federal financial aid (like FAFSA) so it covers what other aid doesn't. LINKS & RESOURCES • Laurel Ridge Nursing — program info, info session registration, application: laurelridge.edu/nursing • Schedule a campus visit: laurelridge.edu/visit • G3 funding eligibility and details: laurelridge.edu/G3  THE VALLEY TODAY with Janet Michael — A decade of conversations. New podcast episodes drop weekdays at 11 AM. Catch the show on The River 95.3 and Fox Sports 1450 AM weekdays just after noon. Subscribe and listen at thevalleytodaypodcast.com — available on Apple Podcasts, Spotify, and wherever you get your podcasts. If you enjoy the show, please take a moment to leave a rating or review — it helps more listeners find us. Connect with us: Facebook — facebook.com/ValleyTodayFanPage Instagram — instagram.com/thevalleytoday

A new, comprehensive study takes a look at lifestyle factors and colorectal cancer in younger people and fails to find a relationship. Kimmel Cancer Center director William Nelson at Johns Hopkins says he thinks it may be more subtle and … Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports Read More »

In trying to discern factors that may account for colorectal cancer incidence in younger people many diet and lifestyle factors fell short, a new study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, points toward insulin … Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports Read More »

Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going … A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read More »

Is the psychedelic renaissance a spiritual threat — or just medicine? In this episode of Refining Rhetoric, host Robert Bortins sits down with Gary Stockton, a Classical Conversations Challenge IV graduate, to discuss his senior thesis: Stay Sober, Stay Alert: A Christian Guide to Mysticism. Gary's 32-source academic argument — drawing from Johns Hopkins research, C.S. Lewis, Voddie Baucham, and Hebrew and Greek primary sources — makes the biblical case that Christians should reject the spiritual experiences offered by psychedelic-assisted therapy. From the ancient cult of Asclepius and pharmakia to Margaret Sanger, Nazi eugenics, and the modern therapeutic boom, Gary traces a chilling historical thread connecting serpentine deities, manufactured spiritual states, and demonic deception across cultures and centuries. Robert and producer Chris Blackburn join Gary to explore what Scripture actually says about mysticism, what Galatians 5 and Deuteronomy 18 reveal about pharmakia, and why the very "benefits" of psychedelic therapy may be part of a much darker bait-and-hook. If you've heard about Joe Rogan's advocacy for psychedelic therapy, Trump's executive order on psychedelics for PTSD treatment, or the growing number of Christians open to these practices — this episode will give you the biblical framework to think clearly and respond wisely.   This episode of Refining Rhetoric is sponsored by Classical Conversations' new 2026 Product Line: This April, Classical Conversations launched an exciting portfolio of new products designed to strengthen math fluency, develop critical reasoning skills, and equip families with practical tools for classical, Christian homeschooling. From flashcard resources and reasoning curriculum to hands-on manipulatives and a foundational parent resource, these releases deepen the classical learning journey for families at every level. Visit https://classicalconversations.com/WhatsNew/ to explore the entire April 2026 product collection and start strengthening your family's classical, Christian education today.

  What if the busyness you've been wearing as a badge of honor is actually the most expensive and most well-defended excuse you've been making for not doing the strategic leadership work your business most urgently needs?  In this episode of That Will Nevr Work, host Maurice sits down with Liz Weber, CMC, CSP — one of fewer than 100 people in the United States to hold both the Certified Speaking Professional® and Certified Management Consultant® designations, founder and President of Weber Business Services, LLC, author of 10 leadership books, named a Top 30 Global Guru on Leadership and Global Top 100 Leadership Influencer, faculty at Johns Hopkins and Georgetown, and a consultant who has worked with organizations across more than 20 countries — for one of the most direct, credentialed, and immediately actionable conversations about leadership, busyness, and strategic clarity we have ever had on this show. Liz does not traffic in motivation or theory. She tells leaders the truth — and then gives them the specific, practical frameworks to act on it. Ace & Arrow  In this episode, you'll discover:Why "I'm so busy" is the most expensive lie in business — and what it's actually covering forThe most costly behaviors in Liz's Stop series — and the single Stop most business owners refuse to makeThe difference between operational planning and genuine strategic leadership — and why it changes everything about how a business growsWhy succession planning is not an exit conversation but an urgent strategic priority for every business owner, right nowHow candid conversations — the ones most leaders systematically avoid — are the ones that change relationships and build the organizations that actually performThe Leadership E.A.S.Y. framework and why the complexity most leaders complain about is almost always self-generatedIf you have been performing busyness while your organization waits for the strategic leadership only you can provide — this episode is the wake-up call you've been too busy to hear until now. 

This week on Catalyst, Tammy is joined by Sezin Palmer, AI Solutions Leader at NTT DATA in North America. Sezin traces her impressive and unconventional journey from CIA analyst and Navy submarine warfare programs to building the National Health Mission area at Johns Hopkins' Applied Physics Lab from scratch, then leading health AI and data at EY. Tammy and Sezin dig into the democratization of AI and what it means that capabilities once locked behind years of data science training are now accessible to nearly anyone. They also discuss the thorny challenge of how organizations decide what not to build and why the hardest leadership problem right now isn't launching AI, it's knowing when to stop. Sezin also shares her vision for what has her most excited: the convergence of software, robotics, and biology. Please note that the views expressed may not necessarily be those of NTT DATALinks: Sezin Palmer Learn more about Launch by NTT DATASee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 138 When One Plus One Equals Three: A Conversation with National Aphasia Synergy               In this episode you will discover: 1.  People with aphasia hold the map. At NAS, people with aphasia don't just have a seat at the table — they built the table. Real peer leadership changes everything about how an organization thinks and acts. 2.  Recovery is about more than speech. The isolation and psychological distress that follow aphasia are just as real as the communication challenges — and just as deserving of attention and support. 3.  Peer-befriending is life participation in action. When people with aphasia support one another through shared experience, that's not a supplement to good care — it is good care. 4.  Sinergia: one plus one equals three. When survivors and professionals work as true equals, something greater emerges than either could create alone. June is National Aphasia Awareness Month, and around here, that means it's time for one of my favorite podcast traditions. For the past few years running, we've spent this month in conversation with people who know aphasia from the inside — those living it every day. Today is no exception, and this one is a conversation I've genuinely been looking forward to.   Welcome to the Aphasia Access Conversations Podcast. I'm Katie Strong from Central Michigan University, where I lead the Strong Story Lab, and I'm a member of the Aphasia Access Podcast Working Group. Aphasia Access is dedicated to transforming services and environments so people with aphasia can participate more fully in life — and today's guests are living proof of exactly what that looks like.         Today I'm speaking with two leaders from National Aphasia Synergy — known as NAS — a peer-led nonprofit founded in 2021 by people with aphasia, for people with aphasia. NAS was built on the belief that those living with aphasia are best positioned to support others on the same journey. Through peer-befriending, technology empowerment, and community building, NAS works to end the isolation that so often follows a stroke — connecting people across the country through a shared sense of what they call Sinergia: the idea that when survivors and professionals work as true equals, one plus one equals three.   Today's conversation feels especially meaningful to me. I've had the privilege of seeing Trish and Amy in action at conferences like Aphasia Access and ASHA — learning from their presentations and watching their advocacy make ripples far beyond those conference walls. As someone who researches friendship and aphasia, I've followed the peer befriending movement closely — it began in the UK, and when I heard that NAS was bringing it to the United States, led by a peer organization, I thought: this is what life participation actually looks like.   Before we get into the conversation, let me tell you a bit more about our guests.   Trish Hambridge is the President and Founder of National Aphasia Synergy. Trish has lived with aphasia since her stroke in 2008, and that experience is the foundation of everything she has built. A former project manager for AppleCare, Trish has become not only a powerful advocate but a published researcher — partnering with research teams to influence the questions being asked and the evidence being built in our field. Her co-authored work spans game-based rehabilitation design, posttraumatic growth in aphasia, and the measurement of motivation and psychological needs in aphasia rehabilitation — all published in leading journals including the American Journal of Speech-Language Pathology. She has spoken at conferences including the Aphasia Access Leadership Summit, Aphasia Access Chautauqua and ASHA, serves on the Disability Advisory Committee in Dunedin, Florida, and is a member of Voices of Hope for Aphasia. Her vision brought NAS to life, and her leadership — in the clinic, in the research literature, and in the community — continues to shape it.   Amy Walters is the Vice President of National Aphasia Synergy. Amy has lived with aphasia since her stroke in 2018 — a stroke that, in a striking twist of fate, occurred while she was attending a neurosurgical conference. A Harvard graduate with a Master of Public Health from Johns Hopkins, Amy spent 30 years as a senior leader in the medical device industry before her stroke, and she has channeled that same expertise and drive into aphasia advocacy. She has presented at neurosurgical conferences to raise awareness, participates in aphasia groups across the country, and brings a remarkable combination of professional knowledge and lived experience to everything NAS does.   So — let's get into the conversation.   Katie Strong: Trish and Amy, welcome. I'm so excited to have you both here today and learn about what's going on in National Aphasia Synergy.   Trish Hambridge: Thank you for the chance to meet.   Amy Walters: We are so pleased to be here with the Aphasia Access Community. Katie Strong: Well, we're delighted that you are sharing your time and expertise with us. I wanted to get started by asking about National Aphasia Synergy. How was it created? Just wondering if you could share the origin story of the organization and how that concept of synergy or working together defines your mission. Trish Hambridge: Long time ago, I had a stroke, major stroke. But I was the same person then as I am now. I remember sitting on the hospital patio in San Jose and Karen, my good friend from college and speech therapist was there, and she was teaching everyone about aphasia. My friends and family were so patient. I remember my Dad talking to me and say, "You are stubborn." and I said, "Thank you!" Because that choice – being subborn - changed everything and gave me the chance to get my identity back. Katie Strong: So, Trish, just to verify, you're saying your stubbornness got you where you are right now. Trish Hambridge: Yes, but yes! Katie Strong: Love it. Trish Hambridge: Sorry to say, I have issues! But going back to the beginning, I had only had five words. Even my 'yes' and 'no' were flipped. Traditional homework is not my cup of tea. Shhh! Quiet, I'm lazy! I needed a better strategy, and I found it with P2Go. It's so much more than an app. It is the tool that gave me my voice back. Katie Strong: I love that, so if I'm understanding correctly, traditional homework is not for you, and that you really needed something that was technology based, which goes back to your expertise in your life, career to be able to really help you communicate, and it was the P2Go. Trish Hambridge: Yeah, yeah, is small, is so, is easy, my opinion. Katie Strong: Well, that's what we're here for today, is your opinion. Trish Hambridge: In 2016, a move to Dunedin, Florida changed everything. I joined Voices of Hope and finally found my community. Then the pandemic hit. But it couldn't stop our connection. We moved to Zoom. I want to be honest, though: some of my friends didn't make it through that storm. Their pain is part of this journey. We build this community in their honor. Katie Strong: Oh, that's really touching, you know. It is. It's hard, so many friends don't stay in our lives for many reasons, but aphasia can really be a challenge for friends sticking around. Trish Hambridge: Yeah, and the technology is not my cup of tea. Katie Strong: Wonderful, wonderful. Thank you for sharing that. Trish Hambridge: In 2021, I stepped up. I moved from a 'Lead Pathfinder' to the Founder of National Aphasia Synergy. I reached out to Debbie Yones, the big cheese of Voices of Hope. She and the Board Director gave me wise advice to help me grow. I didn't do it alone. My sister and my sister-in-law helped me think through the logistics. They helped me build the support for the nonprofit. Because of them, my vision became a reality. Katie Strong: So, your consultation with those important people to your life really helped National Aphasia Synergy become a reality. Trish Hambridge: Yeah. Finally, I asked Amy to join the mission. She became part of the organization. Now, we are moving forward together. Katie Strong: Thanks, Trish. I love that. Amy Walters: Thanks, Trish. Nine years ago, I had my stroke at the neurosurgical conference. Ironic, right? Yeah, the conference was in Colorado Springs. I was in a medically induced coma for 10 days and diagnosed with Global Aphasia. Then I was airlifted to the Shepherd Center in Atlanta, Georgia, where I had a craniotomy and cranioplasty. On the flight I remembered thinking, "Am I in a simulator? What's happening to me?"   Katie Strong: Wow! That sounds surreal! Amy Walters: My career was in clinical affairs for a medical neurosurgical device company, so I am professionally and personally familiar with neuroplasticity. I know how crucial neuroplasticity is to our physical, mental, and emotional recovery. National Aphasia Synergy was born from a deep need for collaborative survivor-led company. Katie Strong: The advocacy you're doing is really amazing, and I'm so excited for our listeners to be able to hear more about it. Amy Walters: Thank you. When we look at the aphasia community today, we see massive gaps. Most organizations are built for us, but they aren't led by us. The 'medical way' focuses only on the speech deficit, but it leaves a gaping hole in mental health, identity, and social connection. The research is heartbreaking: 40% to 60% of stroke survivors with aphasia experience chronic depression, and in early recovery, a staggering 93% experience high levels of psychological distress. This isn't just about the survivor—46% of our family members also face depression. Our mission is to bridge those gaps. We aren't just here to 'fix' speech; we are here to empower the whole person. We call it Sinergia—the Greek word for Synergy. It means we don't work in silos. We don't have 'experts' on one side and 'patients' on the other. We have a partnership where 1 plus 1 equals 3.   Katie Strong: I love it!   Amy Walters: We are moving away from the isolated patient model and toward a Sinergia where survivors and professionals work as equals to reclaim our lives. We are here to educate and empower our peers to use technology to reclaim their voices. But more importantly, we are here to promote peer-befriending. We reach out to those who are new to this path or struggling to find their way, because no one should walk this road alone. Katie Strong: I know, Amy, I just am so excited. I've been watching this peer befriending happen over in the UK, or reading about it, and hearing about it, and I was just so delighted when I heard that National Aphasia Synergy was taking this up and helping us to, to have a really solid connection. I think one of the things that breaks my heart the most is when I meet someone who has aphasia, who's been living with aphasia for a really long time, and they've never met anyone else who had aphasia. Amy Walters: Heartbreaking. Katie Strong: It really is. It really is. Amy Walters: Our goal is to develop a national community that encourages optimism. We believe a positive outlook isn't just a 'nice feeling'—it is a strategy for recovery. Katie Strong: Heck, yes! Amy Walters: At NAS, we don't just look for what's lost; we build on the strengths that remain. There were gaps in the Aphasia Community. Trish Hambridge: Speech Therapists and care partners are vital to recovery. They have good intentions, but the 'medical way' is often the wrong way. Katie Strong: Yeah, yeah, it's not quite the right way. Trish Hambridge: Many researchers only survey the Speech Therapists and the partners. But what about me? What about us? What am I, chopped liver? Think about the last time someone completely iced us out. It hurts, right? It honestly chips away at our sense of self, leaving us clueless as to where we actually fit in. Katie Strong: Yeah, so Trish, just to recap this for the listeners, you're saying when somebody ices you out, you're asking the listeners to reflect on how that really feels, Trish Hambridge: Yeah, I email [a researcher], and have offered [to be a part of their team] but they are like "Oh no, but sorry." Katie Strong: I hear, I hear you. Yeah and I think what you're bringing up - and you and Amy are bringing up such a great point that as the aphasia research community has not always included people with aphasia. Or they're only including people with mild aphasia versus more severe types of aphasia, so I love that you're calling this out and shining light on it. It's, it's time. Trish Hambridge Here's what the research tells us. Therapists and partners see the journey from the outside. But those of us living it? We know the honest truth. Katie Strong: Yeah, yeah, so as the clinicians, the therapists, and the care partners see that journey from the outside, and you all are living it for sure. Trish Hambridge: It is the 'Chicken and the Egg' problem: Does the partner change first? Or does the people with aphasia change? The answer is: The Environment. We must change the environment to find true recovery. We need to move from being 'patients' to being Lead Pathfinders. Katie Strong: Yes, so I love it. You're, you're flipping the script there and reclaiming your identity, or renegotiating it from that patient role to being a lead pathfinder. I love that terminology. Thank you. Thank you. One of you said this earlier that organizations are for people with aphasia, but National Aphasia Synergy is led by people with aphasia. Why is this distinction critical for the community to understand, and how does it change the way an organization is run? Amy Walters: Right, Katie. In the past, organizations were built for us, like a charity. But National Aphasia Synergy is different. We are led by people with aphasia. We are moving from 'being helped' to leading. This is more than an organization. It is a revolution of identity. At National Aphasia Synergy, we are flipping the script on leadership. Our Board makes decisions with one clear priority: putting voices with aphasia at the forefront. That means leaders like Trish, Bruce, and me are the ones making the big calls. We collaborate with wonderful professionals, like Kait, our SLP, Helen, our Financial and Secretarial support and Will Evans, our Volunteer Consultant. They are essential to our success. They ensure our communication is accessible and our business stays strong. I always think of our board meetings being like a United Nations meeting with "international representatives" (i.e., China, France, Japan, etc.) each of us is coming to the table with a different lived experience, different aphasia types, etc. We work together to "translate" and work through our differing communication styles. But make no mistake: The people with aphasia are the primary drivers of the vision. The professionals provide the tools, but we hold the maps.   Katie Strong: Such a great analogy. I love it and it also sounds like your work is fun too.   Amy Walters: Driving you crazy, but you mean you mean you mean, yeah. Hold the phone!   Katie Strong: Oh, that's great. I love it. Well, what does National Aphasia Synergy offer that others should know about? Trish Hambridge: Look at what we have built together: First, our Peer Befriending Program. A team of four SLPs and four people with aphasia worked as equals to create our training. Today, we have 15 volunteer Allies trained and ready to support the community. Katie Strong: I love it. So, 15 people with aphasia, volunteer Allies, have been trained as peer befrienders to go out and connect with other people who newly have aphasia. Trish Hambridge: Right, but anything like… Katie Strong: Or rather, anybody who has aphasia that they're wanting to connect with. Trish Hambridge: Come! Come! But we meet on Zoom.    Katie Strong: On Zoom, right? Yeah, absolutely. This is all virtual, which is amazing, you know, because you get a good reach, a really, a really great reach. What else is going on? Amy Walters: Second, our Aphasia & Mental Health Video. We have four excellent SLPs sharing the research, stats, resources and the power of neuroplasticity. And we also surveyed 10 people with aphasia to capture the honest truth of our emotional journeys and provide 10 essential tips for recovery. Trish Hambridge: I always start with a roadmap. But originally, we were filming something completely different. But three weeks before the shoot, I went to Debbie and asked: 'What do you think?' She said, 'There are enough basic videos out there... why doesn't NAS focus on Mental Health?' Katie Strong: Yeah, okay. So, you were doing all this planning, and then three weeks before the shoot, you went and talked to Debbie and said, "What do you think?" And she said, "There's already enough videos out there on basic aphasia, but not on mental health. I love it! Trish Hambridge: Yeah and so I agree!!! We agreed right away. We made a right turn...  And changed the plan on the fly! I ran a preview for my friends at Voices of Hope. They loved it, but they asked the killer question: 'Where is the actual resource? Where do we go for help?' Katie Strong: Trish, you are speaking to my heart here, and I know I'm one of those "outsider perspectives" as a clinician. But we just don't have great resources for mental health. It's really challenging. So, I love that your friends at Voices of Hope called you out on that. What happened after that? Amy Walters: That was the lightbulb moment, right? Trish Hambridge: Yeah, a video wasn't enough—we needed a map. So, we built the Aphasia and Mental Health Resources paper. The researchers and I had some serious back-and-forth debate, but that's how you get a solid plan. We ended up with something really cool: real tools for real people. Katie Strong: Love, love it! Trish Hambridge: Third, our Adaptive Growth Culture paper. This provides a brand-new map for recovery that the whole world can use to look past the 'broken parts.' Katie Strong: Yeah, Trish, I've heard you speak on this. That talk you gave it, ASHA. I'm going to say listeners, particularly clinicians, you should check this out, because we need to get our clients with aphasia, our lead pathfinders with aphasia to be able to  think in this sort of way, so yeah, Trish Hambridge: But like I have like the speech therapist and the caregiver, and people with aphasia -  it like, look right -- is the good plan. Katie Strong: Love it, fantastic, Amy Walters: Kait and I shared five powerful aphasia stories on video to show our diversity, our strength, our inhumanity, frankly. All of this lives on our National Synergy website. These aren't just projects, they are the proof that when people with aphasia lead, we create world that actually works for us. Katie Strong: Oh, this is fantastic. And we'll have links to your website in the show notes, but you can certainly Google National Aphasia Synergy, and the website pops right up. I've been exploring it for a little bit, but I was looking at it again this morning, and there's just such great, great stuff on there. So please go and check it out. Well, I'm curious, Amy and Trish, what's on the horizon for National Aphasia Synergy, and how can our listeners, whether they're Aphasia Access members or people living with aphasia get involved or support your work. Amy Walters: We are so proud of what we have built, but we are just getting started. This is our Call to Action. Trish Hambridge: We want the world to get excited about Mental Health!  Katie Strong: And I think get excited about your Adaptive Growth Culture too. Trish Hambridge: Yeah! We recently presented a poster at the Chautauqua virtual conference, and the feedback from Aphasia Access members was powerful. The keynote speaker, Dr. Nina Simmons-Mackie, spoke about moving from 'managing a condition' to 'owning a life.' That is exactly what we do! We focus on the strengths, the emotions, and the identity that the old medical model ignores. Katie Strong: Yeah, so okay. So, Trish, you, you were, I think you presented you National Aphasia Synergy presented a poster at the Chautauqua, the Aphasia Access Chautauqua recently. Trish Hambridge: First time presenting a poster! Katie Strong: I love it, I love it. Yep, and the feedback that you got from the Chautauqua attendees was spectacular, right? And that's when, and, and, and Dr. Simmons-Mackie or Nina Simmons Mackey took that idea and we wove it into her keynote at the end, right, and talked about how it's important for us to support people and people with aphasia and care partners move from managing a condition to owning a life. I mean, that that's powerful stuff. I love it! Trish Hambridge: I'm so honored. Katie Strong: Well, you are out there making an impact. Amy Walters: Thank you. We are building something historic, and we want you to be part of it. Here is how you can join the revolution: Trish Hambridge: To the speech therapists and researchers, Help us build our evidence base. We want the test that adapted growth culture map to prove how it improves mental health and builds confidence. Don't just watch from the sidelines—come test this with us! Soon, I'm taking the Adaptive Growth Culture to the global stage. I'll be at the International Aphasia  Rehabilitation Conference in Athens. Katie Strong: You'll be at the International Aphasia Rehabilitation Conference, or IARC, in… Trish Hambridge: Athens!! I am presenting our Adaptive Growth Culture Poster to the top minds in the field. Katie Strong: Fantastic. Trish Hambridge: We have built the roadmap. Now, the researchers will provide the data-driven proof. It is time to see the Adaptive Growth Culture in action. We are moving from lived experience to clinical evidence. Katie Strong: I love it, moving from lived experience to clinical evidence. Amy Walters: That's right, that's right, Trish. If you run a community group, a local program, or a support network, we want to connect with you. Help us build this referral network so that no one is left behind in isolation. We aren't just looking for 'places to go' to pass the time. We are looking for places where we can belong and grow. We are looking for communities that see our potential, not just our deficits. To my peers with Aphasia: Your voice is our power. Share your story or send us a shout-out with your favorite tips and tricks. We also need Buddies for our Peer Befriending program. Help us show the world that we are truly 'owning our lives.' To the Volunteers: We are looking for passionate people to join our Board of Directors. We specifically need one more person with aphasia, as well as SLPs, care partners, and friends. The only requirement? You must believe in the Adaptive Growth Culture. Whether you have the tools or you hold the map, there is a seat at the table for you. Visit us and let's grow together! Katie Strong: Amazing. I hope that our listeners will take you up on the offers that you just laid out there, and that they'll also go out there and share with others that they need to hook everybody up with National Aphasia Synergy. It's a great organization. I enjoyed learning about it more today. And Amy and Trish, I so appreciate you both being here with us and sharing your stories and the amazing work that's going on in National Aphasia Synergy. Trish Hambridge: Thank you. Aphasia Access is fantastic! Katie Strong: I'm glad that you're enjoying Aphasia Access, too. It's a great network, and it's great that we're having lots of communities continue to grow and blossom to support people living successfully with aphasia.   Amy Walters: Hear, Hear! Katie Strong: Thanks. You too. Amy Walters: Thank you. Katie Strong: Have fun in Greece. Trish Hambridge: Yay! Amy Walters: Jealous! Katie Strong: Me too, me too. Amy Walters: Bye, bye. Trish Hambridge: See you. Bye.   On behalf of Aphasia Access, thank you for listening. For references and resources mentioned in today's show, please see our show notes, available on our website at www.aphasiaaccess.org. There you can also become a member of our organization, browse our growing library of materials, and find out about the Aphasia Access Academy. If you have an idea for a future podcast episode, email us at info@aphasiaaccess.org. For Aphasia Access Conversations, here at Central Michigan University in the Strong Story Lab, I'm Katie Strong.     Resources   Below is a list of links to the National Aphasia Synergy (NAS) resources and other organizations as discussed:  NAS Website:  https://nationalaphasiasynergy.org NAS email:  info@nationalaphasiasynergy.org   NAS Facebook page:  https://www.facebook.com/WeRSynergy (to keep up with what's going on at NAS and for inspirational, adaptive growth mindset content) NAS YouTube Channel: https://www.youtube.com/@nationalaphasiasynergy1410 (to watch our Aphasia Stories series, learn about resources, and tune into our quarterly video newsletter, "The Synergy Turf" to hear real people with aphasia) NAS Adaptive Growth Culture paper: https://drive.google.com/file/d/1VIq0juI4FTPKqF0Cev8qZAI5I5po5ouO/view?usp=share_link NAS "You Have Options!" Paper:  https://drive.google.com/file/d/1PBgvb1mDrjnFASaK_dpGL2gnZND_CjaU/view?usp=share_link NAS Aphasia & Mental Health video: https://www.youtube.com/watch?v=GThkxrKbQTI NAS Aphasia & Mental Health Resource paper:  https://drive.google.com/file/d/1pXbFLtZJ8KZ9Pxpg3HVZHBEd_D7BnsED/view?usp=share_link NAS Aphasia Stories video series: https://youtube.com/playlist?list=PLk1GJP6QGrPDOapMhQlmAUBHfVb5-Mnfi&si=BIuoNmeu-TM-ab65NAS  Peer Befriending: To get involved with NAS Peer Befriending, contact  info@nationalaphasiasynergy.org o Flyer:  https://drive.google.com/file/d/1dCETc1pZck59mw6OgaEjZGnXWOcdSlCh/view?usp=sharing o Video:  https://youtu.be/0RNvCeh0BKM   Referenced resources and organizations: Proloquo2Go AAC App mentioned (what Trish uses):  https://www.assistiveware.com/products/proloquo2go Voices of Hope for Aphasia: https://www.vohaphasia.org/    

Part 1:We talk with Jasper Craven, freelance reporter covering men and the military.We discuss how 'manhood' and 'masculinity' is defined, often by the kinds of characteristics that are attributed to military personnel. Elite power-holders attribute these to themselves, even if they have never served.Part 2:We talk with Melvin Goodman, Senior Fellow at the Center for International Policy and Professor of Government at Johns Hopkins.We discuss the office of the Director of National Intelligence, and how it is not truly effective in intelligence gathering or intelligence operations, and why it should be abolished. We also discuss the Democratic Party 'Autopsy' of the last election cycle. We also discuss the US support for Israel's abuses in the Middle East.  WNHNFM.ORG  productionMusic: "That's how every empire falls", John Prine

Cholesterol management, per new guidelines from the American College of Cardiology, is just one aspect of measures you can take to lower your risk for cardiovascular disease, the number one cause of death. Roger Blumenthal, a cardiologist at Johns Hopkins … What's involved in lowering your risk for cardiovascular disease? Elizabeth Tracey reports Read More »

New guidelines for managing cholesterol levels have recently been released by the American College of Cardiology. Cardiologist Roger Blumenthal at Johns Hopkins chaired the committee that wrote the guidelines, and says that in reviewing the data it became clear that … Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports Read More »

In his weekly clinical update, Daniel Griffin and Vincent Racaniello opine on the recent executive order on the routine childhood vaccination schedule, the Ebola outbreak in the Congo and Uganda including the fast track trials for 2 vaccine candidates and antivirals, recent Hantavirus infections, use of quarantined "Hantavirus" patients for the governmental propaganda machine, use of ribavirin and other antivirals for Hantavirus associated cardiopulmonary disease, before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the measles outbreak in Bangladesh, as well as in a daycare center in Texas in 2025, how to access and pay for Paxlovid, FDA approval of a second COVID-19 antiviral drug, where to go for answers about long COVID-19, use of convalescent sera for COVID-19 treatment and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode CIDRAP Op-Ed: What's the likely next move after the executive order on childhood vaccines? (CIDRAP) Ebola dashboard (ebola.fyi) Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern (WHO) WHO ramps up support to the Democratic Republic of the Congo's Ebola outbreak response (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Race begins to trial Ebola drugs amid current outbreak (Nature) Three Ebola vaccine candidates fast-tracked as African outbreak continues (CIDRAP) CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates (CEPI) Obeldesivir (Wikipedia) Hantavirusdashboard (Hantavirus.up) Hantavirus on board with Prof. VincentRacaniello (microbeTV) Scoop: HHS asks confined hantavirus cruise passengers to assist in propaganda (Inside Medicine) Ribavirin (DrugBank) First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib (Clinical Microbiology and Infection) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (IDSA) Deaths following vaccination: what does the evidence show (Vaccine) Bangladesh posts more than 1,300 measles cases, 2 deaths, in 1 day (CIDRAP) Measles Outbreak in a Child Care Facility — Lubbock, Texas, March–April 2025 (CDC:MMWR) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option(xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 FollowingExposure (Businesswire) FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure (MEDPAGE TODAY) The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation/flutter after COVID-19 infection: A retrospective cohort study (PLoS One) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) TWiV 739: COVID-19 convalescent plasma with Arturo Casadevall (microbeTV) COVID-19 L*OVE: the largest open repository of evidence on this pandemic (Epistemonikos) Convalescent plasma for people with COVID‐19 (Cochrane Library) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1328 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Episode 6 in the series marking the 250th Anniversary of the USA in this second quarter 2026. We're covering the first several pages of chapter 3: National Executive Power before the US Constitution but after July 4th, 1776. We discuss pp. 45 thru the top of p.53. When the Founders signed their names onto the Declaration of Independence, they were committing a capital crime, and they were signing their own death warrants if they were caught. They took themselves not to be looking for a fight, but rather, refusing any longer to duck the fight that in fact had come to them. And they sought to ground their cause, their reaction, to right reason in the natural law, consistent with Revelation and the Scriptures. They sought to articulate such an argument for their cause in such a way that would be rightly persuasive to any future reader and any of the nations which may inquire as to the source of their actions. Of course, their cause was initially, in large measure, a reaction against abuse of Executive Power. But such a war required itself strong Executive Power. Therein lies the rub: how can Executive Power be strong yet consistent with the principles of Liberty ? We're making a fair use, transformative reading and discussion of Charles C. Thach's doctoral dissertation at Johns Hopkins in 1922 called "The Creation of the Presidency, 1775-1789 made available by Liberty Fund INC in Indianapolis, Indiana in 2007. Go out and get your physical copy today. Follow along. We'd like to thank Liberty Fund for making this material available, and we'd like to thank Charles C. Thach for writing it. This material was required reading in my Ph.D. program in Public Law and American Politics at The Claremont Colleges. It was used on the 6 hour comprehensive exams (6 hours each) and in a course called The Presidency and the Constitution taught by Joseph M. Bessette, who also served on my dissertation committee many years later. The Republican Professor is a pro-correctly-understanding-the-American-Presidency, anti-grade-inflation-plantation podcast. The Republican Professor is produced and hosted by Dr. Lucas J. Mather, Ph.D.

On this episode of The Jon Gordon Podcast, I sit down with Dr. John Gildea—a pioneering researcher on gut health, soil and healing.   Our conversation goes deeper than science, tracing Dr. Gildea's unlikely journey from the lab at the University of Virginia to becoming an integral voice in the movement to restore health through soil-based nutrition. Dr. Gildea shares how his partnership with Dr. Zach Bush set him on the path to groundbreaking discoveries in gut health. Together, we discuss the debilitating personal battle I faced with gut issues for over a decade, and how his research and soil-derived formula became the catalyst for my healing—a story echoed by countless others. Throughout the episode, we unpack the science behind gut barriers, explain how environmental toxins like glyphosate disrupt our health, and reveal why reconnecting to nature's intelligence can help the body heal itself from the inside out. Dr. Gildea demystifies the complex processes at play, explaining the pivotal role of NRF2 and the remarkable results he's witnessed firsthand—even in the most challenging cases. Whether you're struggling with chronic gut issues, curious about the root causes of inflammation, or seeking hope for true health, this conversation is a testament to breakthrough science and the power of nature's solutions. Tune in for an inspiring reminder that healing is possible and that there are answers waiting for those who refuse to give up. To get the ION product that healed my gut and changed my life go here: Gut Support Skin Support Pet Support ION Homepage SAVE 35% ON ION PRODUCTS NOW - SPECIAL OFFER Visit any of the special ION product links above and enter JONGORDON35 at checkout to save 35%   About Dr. Gildea: Dr. John Gildea Chief Science Advisor | ION* Dr. John Gildea is a Johns Hopkins-trained PhD and cellular biologist with more than 60 peer-reviewed publications across 20+ NIH-funded studies. His research career spans early HIV diagnostics, oncology, and foundational work in kidney physiology, with a particular focus on human-derived cell models to study nutrient absorption, cellular signaling, and the body's mechanisms for maintaining internal balance. As Chief Science Advisor at ION*, Dr. Gildea applies that depth of expertise to questions at the intersection of gut barrier integrity, environmental stress, and cellular response — helping translate rigorous science into meaningful insights for human health.   Here's a few additional resources for you… Do you feel called to share your story with the world? Check out Gordon Publishing  Follow me on Instagram: @JonGordon11 Every week, I send out a free Positive Tip newsletter via email. It's advice for your life, work and team. You can sign up now here and catch up on past newsletters. Ready to lead with greater clarity, confidence, and purpose? The Certified Positive Leader Program is for anyone who wants to grow as a leader from the inside out. It's a self-paced experience built around my most impactful leadership principles with tools you can apply right away to improve your mindset, relationships, and results. You'll discover what it really means to lead with positivity… and how to do it every day. Learn more here! Do you feel called to do more? Would you like to impact more people as a leader, writer, speaker, coach and trainer? Get Jon Gordon Certified if you want to be mentored by me and my team to teach my proven frameworks principles, and programs for businesses, sports, education, healthcare!

Some memoirs tell the story of a life. Others tell the story of survival, identity, and the invisible emotional currents that shape generations. In this episode, I'm joined by physician, healthcare leader, and author Mai Pham to discuss her debut memoir Bridge from Saigon. As a child refugee fleeing Saigon, Mai's journey carried her from war and displacement to institutions like Harvard and Johns Hopkins, eventually leading to influential work shaping Medicare and Medicaid policy. But beneath those achievements lies a deeply personal story about family history, psychological struggle, healing, and the search for belonging. This conversation explores immigration, trauma, medicine, resilience, identity, and what it means to build a bridge between past and present.

Sulforaphane, Detox Pathways, and the Science of Microplastic Removal Microplastics are building up inside your brain, blood, and reproductive tissue, and most detox protocols do nothing to remove them. This episode gives you the cellular science behind why toxins accumulate, which three detox pathways control your ability to excrete them, and what the latest research shows actually moves microplastics, heavy metals, BPA, and benzene out of your body.. -Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR -For next week, 25% off all Mara Labs products when you go to www.mara-labs.com/DAVE and use code DAVE at checkout. After June 11th, the code will return to the standard 15% off. Host Dave Asprey sits down with Dr. John Gildea, a Johns Hopkins-trained PhD with 60 scientific publications and over 20 NIH-funded studies, and David Roberts, co-founder of Mara Labs and co-creator of BrocElite, the only naturally derived stable form of sulforaphane available in a capsule. Together they bring decades of research-backed biohacking and functional medicine insight into one of the most pressing longevity conversations of our time. They break down the lysosome, your cell's built-in incinerator, and explain exactly why it gets clogged with microplastics, advanced glycation end products, and other toxins that won't break down. New research shows that sulforaphane triggers a process called lysosomal surface translocation, which releases those trapped particles so your body can finally excrete them. An in-house Mara Labs study confirmed the excretion pathway: microplastics come out in feces. In the original study, the individual measured the highest microplastic levels ever recorded, and a repeat study a year later showed dramatically lower baseline microplastic levels, suggesting consistent use compounds the benefit over time. You'll Learn: Why microplastics accumulate inside lysosomes and what sulforaphane does to release them How the three detox pathways, glutathione, glucuronidation, and sulfation, work together to remove every major class of toxin What an in-house study revealed about how and where microplastics actually leave the body How toxic estrogen metabolites form and why sulforaphane is the most effective natural tool to reroute them Why berberine supports sleep optimization, ketosis, and blocks a cancer growth pathway most drugs cannot touch How sulforaphane boosts BDNF and neuroplasticity at the cellular level What microplastic sources in your home, including your dryer, rugs, and receipts, are doing to your toxin load daily Why losing weight releases stored toxins and what to take to protect your brain and metabolism during fat loss How sulforaphane activates the same AMPK longevity pathways triggered by fasting without restricting food Thank you to our sponsors! - iRestore | Reverse hair loss at www.irestore.com/DAVE and get exclusive savings on the iRestore Elite, use code DAVE - HeartMath | Go to https://www.heartmath.com/dave to save 15% off. - Timeline | Go to timeline.com/dave and you'll get an additional 20% off your first month - Our Place | Stop cooking with toxic cookware and upgrade to Our Place today. With a 100-day risk-free trial, plus free shipping and returns, you can experience this game-changing cookware with zero risk. Visit: fromourplace.com/DAVE Use code: DAVE for 10% off sitewide Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights inhealth, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: Dr. John Gildea, David Roberts, Mara Labs, BrocElite, sulforaphane, microplastics, microplastic removal, lysosome, lysosomal surface translocation, detox pathways, glutathione, glucuronidation, sulfation, Nrf2 pathway, AMPK, TFEB1, BDNF, neuroplasticity, heavy metals, BPA, benzene, estrogen metabolism, toxic estrogen, xenoestrogens, berberine, BerbaLite, ResveraLite, c-Myc, cancer and estrogen, sleep optimization, ketosis, broccoli sprouts, isothiocyanates, PEITC, watercress, phase two detox, microplastic excretion, indoor air quality, HEPA filter, dryer lint microplastics, BPA receipts, endocrine disruptors, fat loss and toxins, autism and sulforaphane, ADHD and focus, vivid dreams and BDNF, fasting mimicry, anti-aging, biohacking, longevity, functional medicine, supplements, human performance, brain optimization, metabolism, cellular detox Resources: • For next week, 25% off all Mara Labs products when you go to www.mara-labs.com/DAVE and use code DAVE at checkout. After June 11th, the code will return to the standard 15% off. • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Trailer 1:55 – Intro & Context 4:48 – Microplastics & Sulforaphane 12:39 – Broccoli Sprouts Formulation 15:20 – Lab Origin Story 26:01 – Reducing Toxin Exposure 37:06 – Estrogen, Hormones & Berberine 52:46 – Autism, ADHD & Brain Health 59:01 – Wrap-Up See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest host Joe Cirincione interviews David Rothkopf. Rothkopf is the host of the Deep State Radio podcast. He is also Chief Global Affairs Columnist at the Daily Beast and was formerly the editor-in-chief of Foreign Policy magazine. He has taught at Columbia, Georgetown and Johns Hopkins universities. He was the Deputy Undersecretary of Commerce in the Clinton Administration and is the author of ten books including, most recently, Traitor: A History of Betraying America from Benedict Arnold to Donald Trump. His newsletter "Need to Know" is available at davidrothkopf.substack.com. Cirincione talks with Rothkopf about what he calls the unfolding catastrophe of Trump's war on Iran, arguing the U.S. has repeatedly failed in Southwest Asia and that this conflict has achieved neither tactical nor strategic objectives, while causing greater-than-reported damage to U.S. bases and eroding trust in military and government accounts. Rothkopf says the war has weakened U.S. alliances, empowered Iran, Russia, and China, and further damaged America's global standing, while also tying U.S. policy to an increasingly destabilizing Israeli government. The conversation then shifts to domestic consequences, with Rothkopf alleging Trump has monetized the presidency through pervasive corruption, including favors, pardons, and an IRS-related settlement he calls theft from the Treasury. Rothkopf remains hopeful but warns against complacency, argues accountability and progress are linked, and urges resistance ahead of 2026 elections.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Get the free Core Drives in the Wild guide and see behavioral design applied to real products and services: professorgame.com/WildCD Episode Summary Eleanor Ross, Creative Director at Expert Theory and one of the youngest recipients of the National Training and Simulation Association's Top Under 40 award, breaks down how she designs wargames and simulations that put learners inside high stakes decisions instead of watching from the outside. She walks through the moment a Team USA group tried to buy Greenland mid game, the Logic, Function, Form framework she uses to build every simulation, and a year long Taiwan resilience exercise she ran for the Irregular Warfare Center. Listeners come away with two best practices that make any simulation stick, a debrief discipline and deliberate role reversal, plus a clear view of how AI tools now let a team produce news articles and role player materials in under ten minutes. Ross also makes the case that heavy topics like terrorism, invasion, and irregular warfare land harder when they are engaging, and that good design starts by deciding what people should feel when they walk out. About the Host Rob Alvarez is Head of Engagement Strategy, Europe at The Octalysis Group (TOG), a leading gamification and behavioral design consultancy. A globally recognized gamification strategist and TEDx speaker, he founded and hosts Professor Game, the #1 gamification podcast, and has interviewed hundreds of global experts. He designs evidence-based engagement systems that drive motivation, loyalty, and results, and teaches LEGO® SERIOUS PLAY® and gamification at top institutions including IE Business School, EFMD, and EBS University across Europe, the Americas, and Asia. Key Takeaways In an early Arctic simulation run as an alpha test for the Canadian Department of National Defense, a Team USA group went off script and tried to buy Greenland, a move no one had prepared for, which forced Ross to build the response live. Ross and her team at Expert Theory adjudicated that unplanned move and used their AI backend to produce news articles, tweets, and formatted materials for a role player in under ten minutes, a turnaround the wargaming community historically treated as impossible. Her Logic, Function, Form framework stacks design like a pyramid: Logic defines what players should know and feel on the way out, Function defines the actors and goals that get them there, and Form covers constraints like the 30 or 90 minute time box. A quality debrief is the most important best practice in simulation design, because the takeaways people carry out are set up by the structured discussion, not by the game itself. Putting participants in roles they would never hold, such as US military officers playing the Somali government or the US embassy in a Fort Bragg deployment game, forces the perspective shift that makes the lesson land. Ross builds her design philosophy on Rutger Bregman's Humankind and its claim that people are inherently good, using games to surface the nuances behind how opposing sides actually see themselves. Topics Covered 0:00 - A wargamer who hates video games 2:59 - Inside a wargame designer's week 4:18 - When Team USA tried buying Greenland 7:45 - Why failure is a junior mindset 13:02 - A Taiwan resilience wargame for DOD 17:26 - The Logic, Function, Form framework 20:34 - Best practices: debrief and role reversal 24:30 - The books behind her design philosophy 26:33 - Perspective taking through languages 29:27 - Making heavy topics engaging 31:12 - Her favorite game: Votes for Women 33:01 - Building games in six minutes with Providence Get the free Core Drives in the Wild guide and see behavioral design applied to real products and services: professorgame.com/WildCD About Eleanor Ross Eleanor Ross is Creative Director at Expert Theory, an AI powered simulation startup building immersive learning experiences for clients including the U.S. Department of Defense, Johns Hopkins, Duke, Georgetown, and Penn State. She designs and facilitates simulations that restore agency to learners by placing them inside complex, high stakes decisions, and her co-authored research with the National Counterterrorism Innovation, Technology and Education Center has shown that simulations measurably deepen learning while strengthening confidence, teamwork, and decision making. She chairs programming for the Women's Wargaming Network and is one of the youngest ever recipients of the National Training and Simulation Association's Top Under 40 award. Her work focuses on the Arctic and high north, irregular and gray zone warfare, and leadership. Find the Guest Online Expert Theory (website) Eleanor Ross on LinkedIn Expert Theory on LinkedIn Mentioned in This Episode The Art of Wargaming by Peter Perla Humankind by Rutger Bregman Votes for Women, Eleanor's favorite game (by Fort Circle Games) Proposed future guest: Yuna Wong Proposed future guest: John Curry Providence, Expert Theory's platform for building games in minutes Free Resources and Get in Touch Core Drives in the Wild: Professor Game Free Guide Get Daily Value on Your Email Let's chat about your gamification project YouTube LinkedIn Instagram Facebook Start Your Community on Skool for Free Ask a question

Editor's note: Download and listen to the audio version below and click here to subscribe to the Today in Manufacturing podcast.The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN).This week's episode is brought to you by Scientific Cutting Tools (SCT).Working with customers that include NASA, Caterpillar and Johns Hopkins demands a combination of proven and new-age strategies and processes. SCT recently offered a look behind the curtain in detailing how listening to their customers and paying attention to key industry trends has established a legacy of innovative problem-solving and an undeniable focus on cutting edge production and product technologies.These same principles have kept the company competitive for more than 60 years in an increasingly crowded marketplace, and led to internal practices focused on attracting new talent while simultaneously retaining vital experience.To learn more about their secrets to long-term success, download this behind-the-scenes report, "Built on Precision, Grounded in Integrity," right now.Every week, we cover the three biggest stories in manufacturing, and the implications they have on the industry moving forward. This week:- Missing Sticker Triggers Recall for Thousands of Teslas- North Carolina Sues Vietnamese EV Maker After Ongoing Delays- SendCutSend Raises $110 Million to Build 'Anything Factories'In Case You Missed It- Robot With 20 Legs and Eyes Built to Move, See in Any Direction Instantly- Blue Origin's $600 Million Expansion Project to Boost Upper-Stage Production in Florida- Slate Auto Nabs Michigan Grant to Expand EV HQPlease make sure to like, subscribe and share the podcast. And to email the podcast, you can reach any of us at Jeff, Anna or David@ien.com, with “Email the Podcast” in the subject line. Subscribe to our daily and weekly newsletters.

When it comes to ideal LDL cholesterol levels in the blood, ideal is a bit of a moving target. Johns Hopkins cardiologist Roger Blumenthal, chair of an American College of Cardiology committee that has just updated cholesterol guidelines, says it … What LDL cholesterol level should you be aiming for? Elizabeth Tracey reports Read More »

Welcome back to the Audible Bleeding series: Landmark Papers in Vascular Surgery. In this episode, co-hosts John and Dr. Jesse Columbo are joined by our guest, Dr. Caitlin Hicks, to discuss one of the most studied—and most debated—topics in vascular surgery: asymptomatic carotid stenosis.   In this episode, we'll trace that evolution through three pivotal trials: ACAS and ACST-1, which established carotid endarterectomy as the standard of care; and the newly published CREST-2, which challenges us to reconsider everything we thought we knew. Along the way, we'll explore how advances in statin therapy, blood pressure control, and antiplatelet agents have fundamentally changed the natural history of this disease—and what that means for our patients today."   Links to Landmark Papers:  (ACAS) Endarterectomy for Asymptomatic Carotid Artery Stenosis   (ACST-1) 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: a multicentre randomised trial    (CREST-2) Medical Management and Revascularization for Asymptomatic Carotid Stenosis    Guests: Dr. Caitlin Hicks, MD (@CaitlinWHicks); Associate Fellowship Program Director, Vascular Surgery & Endovascular Therapy at Johns Hopkins and Director of Research   Hosts: John Culhane, MD (@JohnCulhaneMD); General Surgery Resident, Abrazo Health Dr. Jesse Columbo, MD; Assistant Professor of The Dartmouth Institute, Geisel School of Medicine, Dartmouth Follow us @audiblebleeding,   Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device. 

What if some people diagnosed with chronic fatigue, fibromyalgia, autoimmune disease, anxiety, or even early Alzheimer's are actually dealing with an underlying infection that was never properly identified? Today, I'm sharing my conversation with Dr. Richard Horowitz, a board-certified internist who has treated more than 13,000 patients with Lyme and tick-borne disease over the last four decades, many of whom had already seen countless doctors and collected diagnoses like chronic fatigue syndrome, fibromyalgia, depression, anxiety, multiple sclerosis, and early dementia before discovering Lyme may have been part of the picture. Dr. Horowitz calls Lyme "the great imitator" because its symptoms can overlap with so many other conditions, and since 2016, Dr. Horowitz has published 11 papers on treatment approaches. In one of his latest studies, he and his colleagues explored a possible connection between Lyme disease and Alzheimer's biomarkers, reporting major improvements in certain inflammatory and cognitive-related markers after treatment. We discuss his broader "MSIDS" model, which looks at chronic illness through a much wider lens. Instead of looking for one single cause, the model examines multiple overlapping factors that may contribute to illness, including infections, toxins, gut dysfunction, nutrient deficiencies, sleep issues, immune imbalance, and inflammation. In this podcast, Dr. Horowitz and I discuss: Why Lyme disease is called "the great imitator" and how it can resemble chronic fatigue syndrome, fibromyalgia, multiple sclerosis, anxiety, depression, and Alzheimer's disease The often-overlooked migratory pain that is one of the hallmark symptoms of chronic Lyme The Lyme symptom questionnaire, which he developed and validated on 6,400 patients How research from Johns Hopkins and other universities changed our understanding of Lyme as a persistent infection Why Dr. Horowitz began using drugs like dapsone and rifampin in Lyme treatment protocols His published research on dapsone combination therapy and the improvements he has observed in patients His recent findings on Lyme disease and Alzheimer's biomarkers, including reductions in tau217 levels Dr. Horowitz's unique MSIDS model and the many overlapping factors that may drive chronic illness Why chronic illness rates continue rising and what conventional medicine may still be missing Why Dr. Horowitz believes recovery is possible, even for patients who have been sick for years  

In his weekly clinical update, Daniel Griffin and Vincent Racaniello comment on incidences of locally transmitted malaria in the US, mpox diagnostics, the latest developments surrounding hantavirus infections, and the Ebola outbreak in the Congo and Uganda including vaccine candidates before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the measles outbreak in Texas in 2025, how to access and pay for Paxlovid, where to go for answers about long COVID-19, casual association of auto-antibodies and COVID complications and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode CDC Operational Guidance for Investigating Locally Acquired Mosquito-Transmitted Malaria — United States, 2026 (CDC: MMWR) Performance of five mpox antigen-based rapid diagnostic tests tested on lesion swabs from patients with suspected mpox from the Kinshasa province of DR Congo: a diagnostic accuracy study (LANCET: Infectious Diseases) Hantavirusdashboard (Hantavirus.up) Andes Hantavirus Outbreak on a Cruise Ship, 2026 (NEJM) "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina (NEJM) Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases) Hantavirus on board with Prof. VincentRacaniello (microbeTV) Ebola dashboard (ebola.fyi) Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern (WHO) WHO ramps up support to the Democratic Republic of the Congo's Ebola outbreak response (WHO: Democratic Republic of Congo) WHO chief says fast-moving Ebola epidemic is outpacing response efforts (Reuters) US CDC seeks staff for Ebola screening as outbreak response expands (Reuters) Trump Administration to Send Americans Exposed to Ebola to Kenya (NY Times) Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus (JID) Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus (PLoS Neglected Tropical Diseases) Vaccine experts debate options to combat outbreak of unusual Ebola strain (Science) NIAID Establishes Centers for Research in Emerging Infectious Diseases (NIAID.NIH) Inside the Race to Develop a Test for the Rare Andes Hantavirus (Wired) NIH terminates network aimed at stopping pandemics before they start (Science) These Researchers Would Be in Africa Fighting Ebola—but Trump Cut Their Funding (Wired) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard(South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Characteristics of Patients Hospitalized with Measles During an Outbreak — West Texas, January–March 2025 (CDC:MMWR) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) US FDA advisers to weigh updating 2026-27 COVID vaccines for XFG variant (Reuters) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID A causallink between autoantibodies and neurological symptoms in long COVID (Cell) Reaching out to US house representative Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of The Joys of Radiology, host Dr. Gautam Agarwal sits down with Dr. Erin Gomez, Assistant Professor of Radiology and Program Director of Diagnostic and Molecular Imaging Residencies at Johns Hopkins, for a conversation about building a meaningful life and career in medicine. Before becoming an award-winning radiologist and educator, Dr. Gomez was an engineering student working with NASA contractors at the Kennedy Space Center. What followed was an unexpected journey into radiology, where she discovered a passion for imaging, education, mentorship, and leadership. Together, they explore what brings joy to radiology, how great educators inspire the next generation of physicians, the evolving role of AI in radiology education, and the importance of creating a sustainable career without sacrificing the things that matter most outside of medicine. From teaching anatomy and mentoring residents to balancing academic medicine with family life, Dr. Gomez shares thoughtful insights on finding purpose, embracing growth, and leading with empathy. Most importantly, she leaves listeners with a simple but powerful piece of advice: "Run toward fear."

Two retired luminaries in geriatrics join us today to share their personal experiences. First, John Burton, a geriatrician and Director of the Division of Geriatric Medicine at Johns Hopkins for some 35 years, shares his journey moving into a Continuing Care Retirement Community (CCRC) during Covid.  You can read about John's early experiences in his JAGS commentary titled, "Waiting for the Other Shoe to Drop."  The tone is bleak.  John's experience since Covid, as you'll hear, is very positive.  Many of the concerns he raised about isolation have been addressed. Second, we hear from Bill Applegate, Geriatrician, retired faculty at Wake Forest, and former Editor in Chief of JAGS (Bill recruited Eric and me to join JAGS as editors about 10 years ago). Bill had a distinctly negative experience in two assisted living facilities (ALFs), which you can read about in his JAGS essay, titled, "My Journey Through Assisted Living Facilities." Bill is seriously concerned about the lack of national oversight, poor staffing, and financial motivations behind for-profit and private-equity owned ALFs. Finally, we hear from Melissa Aldridge, a former banker turned health services researcher, about the rise of private equity purchases of Assisted Living Facilities nationally.  This is a follow up to our prior podcast on private equity gobbling up hospices with Melissa, Lauren Hunt, and Krista Harrison. Melissa is concerned that private equity has a very short time frame to turn acquisitions profitable, and cutting staff is often their first move.  Further, private equity is financing these acquisitions with debt that is increasingly hard to trace and regulate. We talk about how private equity moving from purchasing fast food chains, toy stores, and hotels into CCRC, ALF, nursing home, and hospice ownership is a major concern.  This is not the same as Blackstone buying the Hilton and turning a profit.  These institutions provide healthcare, daily care needs, and community for a huge swath of older adults.  These concerns should trigger a higher level of scrutiny, oversight, and regulation than other industries. What can you do about this, dear listeners?  Listen to the end to find out! Thanks to Jerry Gurwitz for suggesting this podcast.  We appreciate your suggestions. Keep 'em coming. -Alex Smith   

Mary Varghese Presti didn't plan to end up running healthcare AI for one of the most powerful technology companies on earth. She came to the United States at four years old, the daughter of an Indian nurse recruited by Penn Medicine during India's brain drain era. Growing up in Philadelphia in the shadow of one of the world's top nursing schools, she watched her mother and many of the women in her Indian community use the nursing profession as a vehicle for immigration, education, and female empowerment in a generation where very few professional doors were open to them. She began her career as a pediatric nurse at Johns Hopkins. On the floors, she saw everything in a single shift: early cases of congenital HIV, double lung transplants in young children, East Baltimore asthmatic exacerbations. And she kept asking the same question over and over again: why is healthcare organized this way? That single question became a career. From bedside nursing she moved into consulting, working on harmonizing clinical quality measures across NCQA, NQF, AMA and CMS, foundational work that paved the way for value-based care. She helped shape the policy framework that led to meaningful use and the electronic health record adoption wave. She joined Pfizer at the exact moment Lipitor was losing patent protection, watching 10 billion dollars in revenue evaporate in a single year while the entire pharma commercial model was rewritten around her. Today she is the Corporate Vice President and Chief Operating Officer of Microsoft's Health & Life Sciences organization, leading at what she calls one of the few generational shifts in technology in her lifetime. In this episode of Inspiring Women, host Laurie McGraw sits down with Mary to talk about the arc from bedside nursing to Microsoft, from the Manila folder era of medicine to a Stanford pilot where AI agents now compress cancer treatment decisions from weeks and months down to days. They go deep on the AI that hundreds of thousands of physicians are already using today, why nurses describing themselves as "data entry analysts" broke something in her, and what it actually means to build technology that fades into the background instead of getting between a patient and the person caring for them. They discuss: - Growing up as the daughter of an immigrant nurse, and what nursing did for female empowerment in her mother's generation in India - Why she began her career at Johns Hopkins and the moment as a 24-year-old floor nurse that turned her into a systems thinker - The four-act arc of her career across nursing, policy, pharma and technology, and why every zig and zag felt rational at the time - Inside Pfizer during the Lipitor patent cliff, when one drug lost 10 billion dollars in revenue in a single year - Why healthcare still tolerates a digital experience nobody would accept from Uber, Venmo, or online banking - Dragon Copilot for physicians, and how it removes the keyboard from between doctor and patient - Dragon Copilot for nurses, and why nursing workflows demand a fundamentally different technology design - The physical, emotional and cognitive burden that AI is finally lifting off frontline clinicians - The Stanford multi-agent tumor board experiment compressing cancer treatment decisions from weeks to days - Why she refuses to be put in a box as clinician, operator, strategist or policy person, and what a lattice career actually looks like - What she means when she says she expects to remain intrepid for the next five years If you care about the future of healthcare, the real impact of AI on frontline workers, or what a non-linear career built across nursing, policy, pharma and tech actually looks like, this one is for you.

In episode 180, we talk with Tad Stoermer about his book A Resistance History of the United States - the buried stories, the patriot mythology used to contain dissent, and the principles history offers us for meeting the moment we're living through right now.Tad Stoermer is a public historian who trained at the University of Virginia, Johns Hopkins, and Harvard, with a particular focus on Colonial and Revolutionary America. He is also a former congressional staffer and speechwriter, and he served in the US Army and Reserves as a reconnaissance scout. He currently lives in Denmark.Resources: * Tad's Website - Buy A Resistance History of the United States here!* Social Media* Instagram* TikTok* YouTube* BlueskyWe're bringing together digital creators from across the state to build a powerful digital organizing network called Ohio Creators for Progress. Support and donate to this effort below! ⬇️Connect with United SHE Stands:* Substack* Instagram* TikTok* YouTube* Threads* Buy us a coffee ☕️This episode was edited by Kevin Tanner. Learn more about him and his services here:* Website* Instagram This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.unitedshestands.com/subscribe

Today's guest, Anabel Gonzalez, grew up battling baseline depression her whole life, and when she had her son, postpartum hit her like nothing she'd ever experienced. She describes it as "the final boss of depression" and coming out the other side required ketamine infusion therapy, which she says didn't just heal her postpartum depression, it healed a lifelong battle with her brain.But that was only half of the story. After healing her mind, Anabel turned her attention to her body and fell deep into the world of gut health, fermentation, and the microbiome. That obsession led her to identify a gap in the entire probiotic industry: everyone was giving you the same strains on repeat, when diversity is actually the strongest indicator of a healthy gut. So she cold-emailed a Johns Hopkins immunologist, pitched her the idea, and her company, Good Bacteria, was born.We also go pretty deep on mushrooms, spirituality, and the surprisingly philosophical question of what it means to surrender — whether that's in a ketamine chair or on a forest floor. This one ranged wide and I loved every second of it!Use code LUCIE for 25% off at itsgoodbacteria.comSponsors:Tru Fru: Find it now in the freezer aisle of your grocery store.Spindrift: Visit drinkspindrift.com and use code lucie for 15% off.Cotton: Learn more at TheFabricOfOurLives.comWatch this episode in video form on YouTube: https://www.youtube.com/playlist?list=PLjmevEcbh5h5FEX0pazPEtN86t7eb2OgX To apply to be a guest on the show, visit luciefink.com/apply and send us your story. I also want to extend a special thank you to East Love for the show's theme song, Rolling Stone. Follow the show on Instagram: https://www.instagram.com/therealstuffpod Find Lucie here: Instagram: https://www.instagram.com/luciebfink/ TikTok: https://www.tiktok.com/@luciebfink YouTube: https://www.youtube.com/luciebfinkWebsite: https://luciefink.com/ Subscribe to my free newsletter "The Lucie List" here: https://thelucielist.beehiiv.com/subscribeExecutive Producer: Cloud10Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 5 in the series marking the 250th Anniversary of the USA in this second quarter 2026. It should have been episode 4 because we accidentally skipped a ten page section between pp. 23- 33 last time that should have been episode 4, but we will just have those two sections out of chronological order and move on. Today we are doing those pages: pp. 23 -- 33 we had skipped accidentally last time, and then going from where we left off last time on page 40 through to the end of the chapter at p. 44. So, we're discussing pp. 23 through 33, then pp. 40 through 44 to the end of Chapter 2. When the Founders signed their names onto the Declaration of Independence, they were committing a capital crime, and they were signing their own death warrants if they were caught. They took themselves not to be looking for a fight, but rather, refusing any longer to duck the fight that in fact had come to them. And they sought to ground their cause, their reaction, to right reason in the natural law, consistent with Revelation and the Scriptures. They sought to articulate such an argument for their cause in such a way that would be rightly persuasive to any future reader and any of the nations which may inquire as to the source of their actions. Of course, their cause was initially, in large measure, a reaction against Executive Power. But such a war required itself strong Executive Power. Therein lies the rub: how can Executive Power be strong yet consistent with the principles of Liberty ? We're making a fair use, transformative reading and discussion of Charles C. Thach's doctoral dissertation at Johns Hopkins in 1922 called "The Creation of the Presidency, 1775-1789 made available by Liberty Fund INC in Indianapolis, Indiana in 2007. Go out and get your physical copy today. Follow along. We'd like to thank Liberty Fund for making this material available, and we'd like to thank Charles C. Thach for writing it. This material was required reading in my Ph.D. program in Public Law and American Politics at The Claremont Colleges. It was used on the 6 hour comprehensive exams (6 hours each) and in a course called The Presidency and the Constitution taught by Joseph M. Bessette, who also served on my dissertation committee many years later. The Republican Professor is a pro-correctly-understanding-the-American-Presidency, anti-grade-inflation-plantation podcast. The Republican Professor is produced and hosted by Dr. Lucas J. Mather, Ph.D.

Most people think feeling tired, foggy, inflamed, and “off” is just part of modern life.But what if your body is working overtime behind the scenes trying to protect you from a toxic load your grandparents never had to deal with?In this episode of the Kwik Brain podcast, I sit down with David Roberts and Dr. John Gildea, founders of Mara Labs, to unpack what modern toxins, chronic inflammation, and microplastics may be doing to your brain, gut, energy, and recovery.David Roberts' interest in this work began after his late wife, Mara, was diagnosed with breast cancer, a deeply personal experience that pushed him to look more closely at the science of cellular protection and detoxification. Dr. John Gildea is a Johns Hopkins-trained PhD and molecular biologist with decades of research experience in oxidative stress, gene expression, and the body's natural defense systems.We talk about what is really happening when your body feels slower to recover, why brain fog may be one of the earliest warning signs that your system is under stress, and how your detox pathways, inflammation levels, and gut barrier all play a role in how sharp or sluggish you feel.In this episode, you'll learn: ☑️ What sulforaphane is and why it matters for brain health, detoxification, and inflammation ☑️ How chronic inflammation differs from the kind your body uses for healing ☑️ Why brain fog may be linked to toxins, mitochondrial strain, and poor cellular cleanup ☑️ What microplastics are, where most exposure comes from, and why they are such a concern ☑️ How modern life may be overwhelming the body's built-in defense systems ☑️ Why detox is not about extreme cleanses but about supporting the pathways your body already uses ☑️ How gut integrity and tight junctions relate to toxic burden ☑️ Simple ways to reduce toxic exposure and support your body more effectivelyIf you've been feeling like your energy is lower, your thinking is less clear, or your body is not recovering the way it used to, this episode will help you understand what may be happening underneath the surface and what you can do to better support your brain and body in a high-stress, high-toxin world.

It's 1979, and Johns Hopkins has just shut down the first gender surgery clinic in the US. But investigations into the biological roots of gender identity are about to reopen those doors — and reshape how medicine thinks about sex, gender, and who gets to decide.CME: Take the CME Post-Test for this EpisodePublished On: 05/25/2026Duration: 11 minutes, 52 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this

The "Community Meets Clinic" podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we met Dr. Benjamin Greenberg of the UT Southwestern Medical Center. He outlined his translational research, including the Q Study, a Phase 1 trial assessing the safety and feasibility of transplanting human glial restricted progenitor cells into the spinal cord of people who have been diagnosed with transverse myelitis (TM) [05:49]. He also described research on immune-remodeling therapies for NMO aimed at reducing long-term immunosuppression. Dr. Greenberg illustrated multidisciplinary care at UT Southwestern and Children's Medical Center, emphasized options for second opinions and clinician-to-clinician remote consultation, and shared hopes for nervous system repair trials and curative immune therapies [07:18]. You can view Dr. Benjamin Greenberg's medical profile here:https://utswmed.org/doctors/benjamin-greenberg/Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome and Guest Intro01:41 Path to Neurology03:50 Why Neuroimmunology05:49 Research Focus and Trials07:18 Clinic Team and Referrals10:31 Self Care and Hobbies12:17 How the Clinic Can Help14:16 Hope for Future Therapies15:56 Wrap Up

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss withdrawal of the ACIP charter published in April 2026, the first council meeting on antibiotic resistant bacteria, the latest developments surrounding hantavirus infections, and the Ebola outbreak in the Congo and Uganda before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, transmission of SARS-CoV-2 through the air including ventilation systems, how to access and pay for Paxlovid, where to go for answers about long COVID-19, early use of antiviral drugs for COVID-19 patients and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode US health department withdraws vaccine advisory panel charter (Reuters) Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Federal Register) Andes Hantavirus Outbreak on a Cruise Ship, 2026 (NEJM) "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina (NEJM) Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases) Hantavirus on board with Prof. VincentRacaniello (microbeTV) Hantavirus Doesn't Spread Easily, but Officials May Be Downplaying Risks (NY Times) Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection (eBioMedicine) Hantavirus dashboard (Hantavirus.live) Visualizing the hantavirus cruise outbreak in maps and charts (CNN) Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern (WHO) Ebola outbreak response intensifies in DRC and Uganda as cases mount (DG: Alerts) WHO ramps up support to the Democratic Republic of the Congo's Ebola outbreak response (WHO: Democratic Republic of Congo) Vaccine experts debate options to combat outbreak of unusual Ebola strain (Science) US promises to fund clinic established to treat Ebola (X-USForeignAssist) U.S.-Bound Flight Diverted to Canada Because of Ebola Restrictions (NY Times) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option(xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial (Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Potential airborne transmission of SARS-COV-2 through bathroom ventilation ducts associated with an outbreak in a residential building in Santander, Spain, 2020 (PLoS One) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission (JAMA Network OPEN) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Early antiviral use may lower risk of long COVID in mildly ill patients, aid recovery from infection (CIDRAP) Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients (JAMA Network OPEN) Impact of Early Oral Antiviral Use for Outpatients With COVID-19 on Healthcare Utilization and Recovery (ANCHOR-02) (International Journal of Infectious Diseases) Reaching out to US house representative Letters read on TWiV 1324 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Groundbreaking Study Reveals Psilocybin Can CRUSH Smoking Addiction | Dr Matt Johnson Psilocybin Beats Nicotine Patches in BREAKTHROUGH Smoking Trial | Dr Matt Johnson Johns Hopkins Scientist Reveals Psilocybin OUTPERFORMS Patches for Smokers | Dr Matt Johnson Matt Johnson joins Rav Arora on The Illusion of Consensus to discuss his new JAMA Network Open study on psilocybin, nicotine patches, CBT and smoking cessation. A Johns Hopkins psychiatry and behavioural sciences professor, Johnson has been central to modern psychedelic research, including work on psilocybin for addiction, depression and end of life distress. He explains why one psilocybin session paired with CBT showed higher six month smoking abstinence rates than nicotine patch treatment with CBT, and what that could mean for tobacco use disorder. The discussion also covers vaping, nicotine harm reduction, the UK Tobacco and Vapes Bill, addiction treatment, mystical experiences, emotional breakthrough, neuroplasticity, agency and why psychedelics may help people change entrenched behaviour. Rav and his guest examine both the promise and the risks of psychedelic therapy, including bad experiences, vulnerable patients, clinical safeguards and the future of FDA approved addiction treatments. Link to Matt's Paper: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846155 Subscribe to Rav's Substack for exclusive content: https://www.illusionconsensus.com/

Our focus today is on the search for the geriatrician identity, a continuation of the conversation we started with Jerry Gurtwitz on the Future of Geriatrics.  Today's conversation is prompted by multiple articles in JAGS: (1) an article by Jerry Gurwitz with a title the same as this podcast; (2) an article by Helen Fernandez on "Med-Geri", a new combined 4 year internal medicine residency and geriatrics fellowship track; and (3) an article by Mary Tinetti titled, "Mainstream or Extinction: Can Defining Who We Are Save Geriatrics?"  Of note, Mary's article is a follow up to her 2017 article in JAGS in which she wrote: Those outside the field have difficulty understanding what geriatrics is and what geriatricians do. We contribute to this lack of clarity. We are experts in complexity but are often bad at communicating simply. Our well-intentioned efforts to be inclusive and comprehensive lead to the creation of long, complex descriptions of what we do that further compromises understanding while eroding interest in, and support of, our field. Today we tackle this problem, discussing: A "funny if it wasn't so painful" video and JAGS article in which geriatricians from Johns Hopkins roamed the streets of Baltimore asking lay people "What is a geriatrician?"  The responses (something to do with Ben and Jerry's ice cream? Jury-atrician?) will make you laugh and cry at the same time. 4 different types of geriatricians as described by Jerry in his JAGS paper: the complexivist, the healthful longevitist, the syndromist, and the contextualist. As with the 4Ms, Ken couldn't help but add a 5th, the "identityist", arguing that maybe Geriatricians worry too much in public about their identity, and should instead focus in public on what unites them: shared sense of purpose and mission to focus on whole person care and what matters most to older adults. Ken gave a rousing talk on being a Geriatrician at the Society of General Internal Medicine that received a lengthy standing-ovation (and a Cubs Jersey with his name on it).  Innovative new programs such as Med-Geri and GeriPal fellowship as ways to bring more people into the profession. How to balance our effort between recruiting specialist geriatricians to the profession and teaching all clinicians geriatrics principles and skills.   A paper in JAGS by Richard G. Stefanacci and Ankur Patel in JAGS making the argument that a geriatrician "yields per-patient annual net cost savings of approximately $3495 (specialist consultation avoidance +$1500; ED reduction +$45; hospitalization reduction +$1950)..." and "The reason fee-for-service fails geriatricians is not that their skills are wrong for primary care—it is that the payment model is wrong for their skills. Payvider programs operating under capitation invert every structural disadvantage of fee-for-service. Under capitation, there are no RVUs. There is no penalty for spending 40 min with a complex patient. There is no revenue loss when the patient is dual-eligible rather than commercially insured—the capitated payment is the same regardless of original coverage source. And every unnecessary specialist referral, every avoidable hospitalization, every ED visit that could have been managed in-house represents a cost to the organization rather than a revenue stream." Stay until the end when Mary has one of the best answers yet (in over 400 podcasts!) to Eric's "if you had a magic wand" question. Enjoy! -Alex Smith

Up to 1 in 5 people may have this condition and never know it and the diagnoses they've been handed instead, from PCOS to IBS to chronic fatigue, may all be pointing at the same hidden cause. In this episode, I sit down with Dr. Tania Dempsey, Johns Hopkins-trained internist and one of the leading researchers on Mast Cell Activation Syndrome, who tells me that 100% of her PCOS patients test positive for MCAS, and walks me through why mast cells may be the most overlooked driver of chronic illness in modern medicine. If you've been told your symptoms are idiopathic, or that nothing's wrong even though everything feels wrong, this is the conversation that finally connects the dots. CLICK HERE TO BECOME GARY'S VIP!: ⁠https://bit.ly/4ai0Xwg⁠ Get Dr. Tania Dempsey's audio book, “Mast Cell Matters”: ⁠https://bit.ly/4drrnOf⁠  Listen to Dr. Tania Dempsey on all your favorite platforms! YouTube: ⁠https://bit.ly/4dcVlqs⁠  Spotify: ⁠https://bit.ly/4dsS9G2⁠  Apple Podcasts: ⁠https://bit.ly/3PjGhy6⁠  Connect with Tania Dempsey Website: ⁠https://bit.ly/4dKXgTe⁠  YouTube: ⁠https://bit.ly/4dcVlqs⁠   Instagram: ⁠https://bit.ly/4f7kHrd⁠  Facebook: ⁠https://bit.ly/3R6sOdz⁠   LinkedIn: ⁠https://bit.ly/4ddPilv⁠   Thank you to our partners A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD AIRES: "ULTIMATE20 " FOR 20% OFF: https://bit.ly/4a3Duze BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp CYMBIOTIKA: "ULTIMATE10" FOR 10% OFF: https://bit.ly/4tjyluP GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): ⁠https://bit.ly/3Yg1Uk9 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC H2TAB: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S PEPTUAL: “TUH10” FOR 10% OFF: https://bit.ly/4mKxgcn SNOOZE: LET'S GET TO SLEEP!: https://bit.ly/4pt1T6V WHOOP: JOIN & GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW Watch  the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: ⁠https://bit.ly/3RPQYX8⁠ Podcasts: ⁠https://bit.ly/3RQftU0⁠ Connect with Gary Brecka Instagram: ⁠https://bit.ly/3RPpnFs⁠ TikTok: ⁠https://bit.ly/4coJ8fo⁠ X: ⁠https://bit.ly/3Opc8tf⁠ Facebook: ⁠https://bit.ly/464VA1H⁠ LinkedIn: ⁠https://bit.ly/4hH7Ri2⁠ Website: ⁠https://bit.ly/4eLDbdU⁠ Merch: ⁠https://bit.ly/4aBpOM1⁠ Newsletter: ⁠https://bit.ly/47ejrws⁠ Ask Gary: ⁠https://bit.ly/3PEAJuG⁠ Timestamps 00:00 ​Intro of Show 03:52 - The biology of mast cells 05:34 - Inflammation, allergies, and dystrophisms 09:00 - Connective tissue, POTS, and Ehlers-Danlos 09:40 - Gary's daughter and the toxic load 13:24 - Symptoms from head to toe 18:20 - GLP-1 receptors on mast cells 23:47 - Identifying the upstream triggers 27:38 - Treating viral and bacterial loads 31:35 - The herpes virus family and reactivation 35:47 - SOT therapy and targeted mRNA 38:17 - The immunofatigue theory of aging 45:03 - Therapeutic plasma exchange and detox 58:09 - Gut dysbiosis and the microbiome 1:00:58 - Cryptosporidium and parasite testing 1:06:30 - Hope and the path forward Disclaimer: This podcast is for informational purposes only and does not provide medical advice. It is not intended for diagnosing or treating any health condition. Always consult a licensed healthcare professional before making health or wellness decisions. Gary Brecka is the owner of Ultimate Human, LLC which operates The Ultimate Human podcast and promotes certain third-party products used by Gary Brecka in his personal health and wellness protocols and daily life and for which Ultimate Human LLC and / or Gary Brecka directly or indirectly holds an economic interest or receives compensation.  Accordingly, statements made by Gary Brecka and others (including on The Ultimate Human podcast) may be considered.  Learn more about your ad choices. Visit megaphone.fm/adchoices

In 1966, Johns Hopkins opened the first gender surgery clinic in the US. Thirteen years later, a single study shut it down. We examine what the research said, what it didn't say, and how new standards of care emerged from the ashes.CME: Take the CME Post-Test for this EpisodePublished On: 05/18/2026Duration: 13 minutes, 39 secondsChris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this